Clinical Trials Browser

Phase 1/2 × Lymphoma, T-Cell, Peripheral × copanlisib × Clear all

NCT03052933 2022-06-10

Copanlisib and Gemcitabine in Relapsed/Refractory PTCL

Phase 1/2 Completed

Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell